Chiyo K. Imamura

Significant Effect of Polymorphisms in<i>CYP2D6</i>and<i>ABCC2</i>on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients

Kazuma Kiyotani, Taisei Mushiroda, Chiyo K. Imamura et al. · Journal of Clinical Oncology · 2010 · 223 citations · Full text

The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV

Hiroaki Akamatsu, Kiichiro Ninomiya, Hirotsugu Kenmotsu et al. · International Journal of Clinical Oncology · 2019 · 145 citations · Full text

Optimizing antiemetic treatment for chemotherapy-induced nausea and vomiting in Japan: Update summary of the 2015  Japan Society of Clinical Oncology Clinical Practice Guidelines for Antiemesis

Kenjiro Aogi, Hideki Takeuchi, Toshiaki Saeki et al. · International Journal of Clinical Oncology · 2020 · 107 citations · Full text

Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205)

Kohei Shitara, Toshihiko Doi, Osamu Nagano et al. · Gastric Cancer · 2016 · 99 citations · Full text

Dose-escalation Study, Advanced Gastric Cancer, Medicine +6

Dose-adjustment study of tamoxifen based on CYP2D6 genotypes in Japanese breast cancer patients

Kazuma Kiyotani, Taisei Mushiroda, Chiyo K. Imamura et al. · Breast Cancer Research and Treatment · 2011 · 92 citations

Cyp2d6 Genotypes, Breast Oncology, Oncology +8